Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$119,185,588
in 10 filings, $2.7M under 10b5-1 plans

Net −$119,185,588. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-09 Murcko Mark Director Grant or award · Stock Option (Right to Buy) +32,947 32,947
2025-06-06 Murcko Mark Director Grant or award · Stock Option (Right to Buy) +136,681 136,681
2024-06-03 Murcko Mark Director Grant or award · Stock Option (Right to Buy) +102,225 102,225
2023-05-31 Murcko Mark Director Grant or award · Stock Option (Right to Buy) +66,055 66,055
2022-09-08 Murcko Mark Director Sale −25,000 $29.95 $749K 996,952
2022-05-27 Murcko Mark Director Grant or award · Stock Option (Right to Buy) +41,597 41,597
2021-05-19 Murcko Mark Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2020-07-20 Murcko Mark Director Conversion +281,617 718,123
2020-07-20 Murcko Mark Director Conversion +278,829 996,952
2020-07-20 Murcko Mark Director Purchase +25,000 $20.00 $500K 1,021,952
2020-07-20 Murcko Mark Director Conversion · Series A Convertible Preferred Stock −1,000,000 0
2020-07-20 Murcko Mark Director Conversion · Series B Convertible Preferred Stock −990,099 0

Page 1 of 1 · 12 trades